Poor health outcomes in infants with vitamin B 12 deficiency include anemia, abnormal skin and hair development, convulsions, weak muscle tone, failure to thrive, mental developmental delay, and potentially abnormal movements.[4-8] Well-recognized at risk groups are exclusively breastfed infants of mothers with B 12 deficiency due to minimal or no dietary intake of animal products[9-21] or pernicious anemia caused by a maternal malabsorption of B 12 .[18,22] Infant vitamin B 12 status can be improved through maternal B 12 supplementation during pregnancy and lactation.[23-26] Deficient mothers who miss the opportunity to supplement during pregnancy should still be encouraged to supplement during early lactation since infant vitamin B 12 status correlates with milk vitamin B 12 levels in breastfed infants up to 6 months of age.[27-30] Although there are cases reported of exclusively breastfed infants with vitamin B 12 deficiency having biochemical and clinical improvement through adequate maternal supplementation alone,[9] direct supplementation of the infant is recommended when such treatments are available.[31-33] Drug Levels Methylcobalamin is the major form of vitamin B 12 in milk
Immunomodulatory integration: nano-formulated PD-1 blockade therapies modulate macrophage polarization and suppress NLRP3 inflammasome activation, mitigating chronic inflammatory damage in gouty arthritis (Liu Y
One practical consequence of the triple mechanism: because three pathways are being engaged simultaneously, the total physiological load at any given milligram is higher than a single- or dual-agonist at the same number
Another study shows the correlation between estrogen receptor (ER) gene polymorphisms (PvuII and XbaI polymorphisms for the ER gene and AluI and RsaI polymorphisms for the ER gene) and melasma incidence
Solem, E., Tuczek, F
